Our 5-minute online survey conducted in the fall of 2020 sought to gain clarity around remote detailing. This study was conducted with 339 Canadian physicians who are members of the MD Analytics healthcare panel and the results provide actionable recommendations on how to form a more ‘ideal’ pharma remote detail.
We polled n=114 Canadian General Practitioners (GPs) and n=205 Pharmacists (Pharms) on their willingness to see sales representatives, the effect detailing has on their behaviour, and what companies can do to improve the overall experience.
88% of GPs and 86% of Pharms agree that sales reps add value to their practice and aid in better treating their patients. In addition, sales reps also positively impact their willingness to use a product, knowledge of a product and knowledge of additional support offered by the manufacturer.
However, roughly half of all GPs and Pharms say they feel overwhelmed with requests on their time from sales reps. The majority of GPs and Pharms agree they are willing to give more of their time for a detail that is engaging, educational, and impactful.
Past Quick Polls
The COVID-19 crisis has significantly impacted physicians’ practices; but how and to what extent? Physicians have been managing significant workloads, while learning on the fly how to navigate and setup virtual meetings. Maintaining high levels of patient care while minimizing in-person interactions has also been challenging.
Strong online advertising and messaging are key to maximizing impact of any marketing campaign. With recent restrictions on in-person interactions, online advertising and messaging play an even greater role in reaching physicians. Our findings from a survey of n=227 Canadian physicians show that 82% of Canadian physicians have increased their use of online platforms as a result of COVID-19, 48% significantly so.
Physicians recognize that new medications often can be quite valuable for their patients and are eager to add them to their armamentarium. However, they do not always end up prescribing these new medications as much as they initially plan or as early as they would like. There are many reasons that can explain this discrepancy.
Past Quick Polls
Physicians recognize that new medications often can be quite valuable for their patients and are eager to add them to their armamentarium. However, they do not always...